169674-35-5

Basic information

• Product Name: 5,6-DIFLUOROINDOLE-2-CARBOXYLIC ACID
• Synonyms: 5,6-DIFLUOROINDOLE-2-CARBOXYLIC ACID;5,6-DIFLUOROINDOLE-2-CARBOXYLIC ACID, 98+%;5,6-DIFLUORO-1H-INDOLE-2-CARBOXYLIC ACID
• CAS NO: 169674-35-5
• Molecular Formula: C9H5F2NO2
• Molecular Weight: 197.14
• Product Categories: Indole/indoline/oxindole;Indole and Indoline;Indole;Indoles
• Mol File: 169674-35-5.mol

Chemical Properties

• Boiling Point: 427.4 °C at 760 mmHg
• Flash Point: 212.3 °C
• Appearance: /
• Density: 1.605 g/cm³
• Vapor Pressure: 0.00208mmHg at 25°C
• Refractive Index: 1.657
• Storage Temp.: 2-8°C
• PKA: 4.21±0.30(Predicted)
• Sensitive: Light Sensitive
• CAS DataBase Reference: 5,6-DIFLUOROINDOLE-2-CARBOXYLIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 5,6-DIFLUOROINDOLE-2-CARBOXYLIC ACID(169674-35-5)
• EPA Substance Registry System: 5,6-DIFLUOROINDOLE-2-CARBOXYLIC ACID(169674-35-5)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-37/39
• Hazardous Substances Data: 169674-35-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
5,6-Difluoroindole-2-carboxylic acid is utilized as an intermediate compound for the synthesis of various pharmaceutical drugs. Its unique structure and fluorine content make it a valuable building block in the development of new medications, particularly those targeting specific biological pathways or receptors.
Used in Agrochemical Industry:
In the agrochemical sector, 5,6-Difluoroindole-2-carboxylic acid serves as a key component in the formulation of pesticides and other crop protection products. Its chemical properties allow for the creation of effective and targeted agrochemicals that can protect crops from pests and diseases while minimizing environmental impact.
Used in Research and Development:
5,6-Difluoroindole-2-carboxylic acid is also employed in academic and industrial research settings as a model compound for studying the effects of fluorination on molecular properties and reactivity. This knowledge can be applied to the design of new compounds with improved performance in various applications, such as drug discovery or materials science.

InChI:InChI=1/C8H5ClFN/c9-6-3-5-1-2-11-8(5)4-7(6)10/h1-4,11H

Upstream product

• 127-17-3 2-oxo-propionic acid 
• 847685-01-2 2-iodo-4,5-difluoroaniline 
• 3863-11-4 3,4-difluoroaniline 
• 169674-34-4 ethyl 5,6-difluoro-1H-indole-2-carboxylate 

Downstream Products

• 898746-30-0 methyl 5,6-difluoro-1H-indole-2-carboxylate 
• 1350888-86-6 (E)-5-bromo-N'-(1-(5,6-difluoro-1H-indol-2-yl)ethylidene)-2-hydroxybenzohydrazide 

Relevant articles and documents

Structure-based optimisation of orally active & reversible MetAP-2 inhibitors maintaining a tight ‘molecular budget’

Structure-based led optimisation of orally active reversible Methionine Aminopeptidase-2 (MetAP-2) inhibitors utilising a ‘molecular budget’ medicinal chemistry strategy is described. The key physicochemical parameters of target molecules (cLogP, molecula

ANTI-BACTERIAL PYRUVATE KINASE MODULATOR COMPOUNDS, COMPOSITIONS, USES, AND METHODS

Compounds having a structure of Formulas A-C are provided. Uses of such compounds as an antibiotic, including both gram-negative and gram-positive micro-organisms, as well as methods of treatment and uses involving such compounds are provided.

Optimization and structure-activity relationships of a series of potent inhibitors of methicillin-resistant Staphylococcus aureus (MRSA) pyruvate kinase as novel antimicrobial agents

A novel series of hydrazones were synthesized and evaluated as inhibitors of methicillin-resistant Staphylococcus aureus (MRSA) pyruvate kinase (PK). PK has been identified as one of the most highly connected 'hub proteins' in MRSA. PK has been shown to b

INDAN-AMIDE DERIVATIVES WITH GLYCOGEN PHOSPHORYLASE INHIBITORY ACTIVITY

A compound of the formula (1) or a pharmaceutically-acceptable salt: (A chemical formula should be inserted here - please see paper copy enclosed herewith) (1) possess glycogen phosphorylase inhibitory activity and accordingly have value in the treatment

Indole derivatives

The invention releates to indole derivatives of the formula STR1 wherein R 1 to R 4 are, independently, hydrogen, halogen, lower-alkyl, cycloalkyl or trifluoromethyl, R 5 and R 6 are, independently, hydrogen, halogen, lower-alkyl, cycloalkyl, trifluoromet